Mobile app version of munafa.co.com
Login or Join
 Learn then Earn
stockMarketNEWS

 story : GlaxoSmithKline, Vir increases supply of COVID-19 antibody therapy to Canada to 20,000 doses #FinanceUSA #StockMarketNEWS GlaxoSmithKline PLC announced Thursday an agreement to supply the Government

@stockMarketNEWS Sun 09 Jan, 2022

Posted in: #FinanceUSA #StockMarketNEWS

GlaxoSmithKline, Vir increases supply of COVID-19 antibody therapy to Canada to 20,000 doses #FinanceUSA #StockMarketNEWS
GlaxoSmithKline PLC announced Thursday an agreement to supply the Government of Canada with 20,000 doses of Sotrovimab, the COVID-19 monoclonal antibody therapy the company developed with Vir Biotechnology Inc. . The agreement follows Canada's initial order of 10,000 doses of Sotrovimab announced in October, which included options for additional purchases. Sotrovimab was authorized for injection by Health Canada in July 2021 to treat mild to moderate COVID-19 in adults and adolescents 12 years old and older who are at high risk for hospitalization and death. Glaxo's stock slipped 0.1% in afternoon trading and Vir shares eased 0.1%, while the S&P 500 gained 0.1%.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme